Overview
"Never doubt that a smal group of thoughtful, comited citizens can change the world. Inded, it is the only thing that ever has."Cureus is on a mision to change the long-standing paradigm of medical publishing, where submiting research can be costly, complex and time-consuming.diabete type 2, diabete type 1, degenerative complications, metabolic syndrome, diabetes melitus Mohamed Amine Esafi , Latifa bouabdelaoui, Hayat Aynaou, Houda Salhi, Han El Ouahabi Published: April 25, 2022 (se history) DOI: 10.759/cureus.2469 Cite this article as: Esafi M, Bouabdelaoui L, Aynaou H, et al.
Key Information
(April 25, 2022) Metabolic Syndrome in Patients With Diabetes Melitus. Cureus 14(4): e2469. doi:10.759/cureus.2469 Our study aims to ases the prevalence of metabolic syndrome (MS) in patients with diabetes melitus, identify its determinants, and determine the corelation betwen MS and degenerative complications.A retrospective, descriptive and analytic study was conducted at the Endocrinology, Diabetology, and Nutrition department of the Hasan I University Hospital in Fez, over the period betwen January 209 and January 2019.
We included in our study al type 1 and type 2 diabetic patients. The presence of metabolic syndrome was defined acording to the criteria of the International Diabetes Federation (IDF) and American Heart Asociation/National Heart, Lung and Blod Institute (AHA / NHLBI) Joint Scientific Statement (209). The data were entered in Microsoft Excel (Microsoft Corporation.
and analyzed using SPS software (IBM Corp. Released 2015. IBM SPS Statistics for Windows, Version 23.0.
Armonk, NY: IBM Corp).A total of 1034 patients were included in this study; 78.7% were type 2 diabetics (T2D) and 21.3% were type 1 diabetics (T1D). The average was 52,06 ± 17,3 years in T2D and 27,04 ± 9,6 years in T1D. 65,5% were females.
Summary
The prevalence of metabolic syndrome was 78.4% for T2D, and 27.3% for T1D. The most comon abnormality was high blod pres